InsidersTradesSigma
Explore the complete record of transactions filed by Galli Stephen J, Director. Officer active across 1 companies, notably Atossa Therapeutics, INC.. Aggregated, 2 filings have been published. The latest transaction was filed on 12 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Stephen J. Galli is a Director at Atossa Therapeutics, Inc. He brings his expertise in strategy and governance to the board. Atossa Therapeutics is a company specializing in developing treatments for breast diseases. Mr. Galli plays an active role in strategic direction and oversight of the company's operations.